Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK

被引:83
作者
Kapil, Vikas [1 ,2 ,3 ,4 ]
Green, Jody L. [5 ]
Le Lait, Marie-Claire [5 ]
Wood, David M. [1 ,2 ,6 ]
Dargan, Paul I. [1 ,2 ,6 ]
机构
[1] Guys & St Thomas NHS Fdn Trust, London, England
[2] Kings Hlth Partners, London, England
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Clin Pharmacol, William Harvey Res Inst, London, England
[4] Barts Hlth NHS Trust, London, England
[5] Denver Hlth Rocky Mt Poison & Drug Ctr, Denver, CO USA
[6] Kings Coll London, London WC2R 2LS, England
关键词
WITHDRAWAL;
D O I
10.1111/bcp.12277
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:190 / 191
页数:2
相关论文
共 8 条
[1]  
[Anonymous], NEUR PAIN PHARM MAN
[2]  
EMCDDA, 2010, 2010 ANN REP STAT DR
[3]  
Home Office Statistics Unit/Office for National Statistics, DRUG MIS DECL FIND 2
[4]   Baclofen and gamma-hydroxybutyrate withdrawal [J].
LeTourneau, Jennifer L. ;
Hagg, Daniel S. ;
Smith, Stephen M. .
NEUROCRITICAL CARE, 2008, 8 (03) :430-433
[5]   Pregabalin in clinical psychiatry and addiction: pros and cons [J].
Martinotti, Giovanni .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (09) :1243-1245
[6]  
NHS Prescription Services, CENTR NERV SYST NAT
[7]   Is There a Recreational Misuse Potential for Pregabalin? Analysis of Anecdotal Online Reports in Comparison with Related Gabapentin and Clonazepam Data [J].
Schifano, Fabrizio ;
D'Offizi, Stefano ;
Piccione, Michele ;
Corazza, Ornella ;
Deluca, Paolo ;
Davey, Zoe ;
Di Melchiorre, Giuditta ;
Di Furia, Lucia ;
Farre, Magi ;
Flesland, Liv ;
Mannonen, Miia ;
Majava, Aino ;
Pagani, Stefania ;
Peltoniemi, Teuvo ;
Siemann, Holger ;
Skutle, Arvid ;
Torrens, Marta ;
Pezzolesi, Cinzia ;
van der Kreeft, Peer ;
Scherbaum, Norbert .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2011, 80 (02) :118-122
[8]   Acute toxicity and withdrawal syndromes related to gamma-hydroxybutyrate (GHB) and its analogues gamma-butyrolactone (GBL) and 1,4-butanediol(1,4-BD)1 [J].
Wood, David M. ;
Brailsford, Alan D. ;
Dargan, Paul I. .
DRUG TESTING AND ANALYSIS, 2011, 3 (7-8) :417-425